NEW YORK (GenomeWeb) – After posting a 6 percent gain in January, the GenomeWeb Index rose nearly 5 percent in February, on par with the Dow Jones Industrial Average, and outperforming a 4 percent gain from the Nasdaq. The Index underperformed the Nasdaq Biotechnology Index, however, which gained 7 percent in February.

Stock performance in the February GenomeWeb Index was almost entirely positive, with 22 of the 26 stocks seeing gains and only four seeing losses. Many of the gains and losses in February were less dramatic than the ones last month, however.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.